EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Maternal tadalafil treatment does not increase uterine artery blood flow or oxygen delivery in the pregnant ewe

Jack R T Darby iD, Dimitra Flouri iD, Steven K S Cho, Georgia K Williams iD, Stacey L Holman iD, Ashley S Meakin iD, Michael D Wiese iD, Anna L David iD, Christopher K Macgowan iD, Mike Seed iD, Andrew Melbourne iD, Janna L Morrison iD

Experimental Physiology · 2024

DOI: 10.1113/ep091593 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Experimental Physiology, 2024. Verfasst von Jack R T Darby und 11 weiteren Autor:innen. Beteiligte Einrichtung: Early Origins of Adult Health Research Group, Health and Biomedical Innovation, UniSA: Clinical and Health Sciences, University of South Australia, A…. Hauptthemen laut MEDLINE: Tadalafil, Uterine Artery, Placenta, Placental Circulation. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ames Research Center NASA, Australian Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Increasing placental perfusion (PP) could improve outcomes of growth‐restricted fetuses. One way of increasing PP may be by using phosphodiesterase (PDE)‐5 inhibitors, which induce vasodilatation of vascular beds. We used a combination of clinically relevant magnetic resonance imaging (MRI) techniques to characterize the impact that tadalafil infusion has on maternal, placental and fetal circulations. At 116–117 days’ gestational age (dGA; term, 150 days), pregnant ewes ( n = 6) underwent fetal catheterization surgery. At 120–123 dGA ewes were anaesthetized and MRI scans were performed during three acquisition windows: a basal state and then ∼15–75 min (TAD 1) and ∼75–135 min (TAD 2) post maternal administration (24 mg; intravenous bolus) of tadalafil. Phase contrast MRI and T 2 oximetry were used to measure blood flow and oxygen delivery. Placental diffusion and PP were assessed using the Diffusion‐Relaxation Combined Imaging for Detailed Placental Evaluation—‘DECIDE’ technique. Uterine artery (UtA) blood flow when normalized to maternal left ventricular cardiac output (LVCO) was reduced in both TAD periods. DECIDE imaging found no impact of tadalafil on placental diffusivity or fetoplacental blood volume fraction. Maternal‐placental blood volume fraction was increased in the TAD 2 period. Fetal and were not affected by maternal tadalafil administration. Maternal tadalafil administration did not increase UtA blood flow and thus may not be an effective vasodilator at the level of the UtAs. The increased maternal–placental blood volume fraction may indicate local vasodilatation of the maternal intervillous space, which may have compensated for the reduced proportion of UtA .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TadalafilUterine ArteryPlacentaPlacental CirculationOxygenAnimalsFemalePregnancySheepRegional Blood FlowPhosphodiesterase 5 InhibitorsMagnetic Resonance ImagingFetus

Stichwörter der Autor:innen

fetal MRIfetal developmentfetal growth restrictionhaemodynamicsmagnetic resonance imagingplacental perfusiontadafertadalafil

Substanzen

TadalafilOxygenPhosphodiesterase 5 Inhibitors

Autor:innen und Institutionen

  • Early Origins of Adult Health Research Group, Health and Biomedical Innovation, UniSA: Clinical and Health Sciences, University of South Australia, Adelaide, South Australia, Australia.
  • School of Biomedical Engineering and Imaging Sciences, King's College London, London, UK.
  • Univeristy of Toronto and The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Preclinical, Imaging & Research Laboratories, South Australian Health & Medical Research Institute, Adelaide, Australia.
  • Centre for Pharmaceutical Innovation, UniSA: Clinical and Health Sciences, University of South Australia, Adelaide, South Australia, Australia.
  • Elizabeth Garrett Anderson Institute for Women's Health, University College London, London, UK.

ORCID-Profile: Jack R T Darby, Dimitra Flouri, Georgia K Williams, Stacey L Holman, Ashley S Meakin, Michael D Wiese, Anna L David, Christopher K Macgowan, Mike Seed, Andrew Melbourne, Janna L Morrison

Förderung

  • Ames Research Center NASA
  • Australian Research Council

Zitieren

APA

Darby, J. R. T., Flouri, D., Cho, S. K. S., Williams, G. K., Holman, S. L., Meakin, A. S., Wiese, M. D., David, A. L., Macgowan, C. K., Seed, M., Melbourne, A., & Morrison, J. L. (2024). Maternal tadalafil treatment does not increase uterine artery blood flow or oxygen delivery in the pregnant ewe. Experimental Physiology. https://doi.org/10.1113/ep091593

Vancouver

Darby JRT, Flouri D, Cho SKS, Williams GK, Holman SL, Meakin AS, et al. Maternal tadalafil treatment does not increase uterine artery blood flow or oxygen delivery in the pregnant ewe. Experimental Physiology. 2024. doi:10.1113/ep091593

BibTeX
@article{Darby2024,
  author = {Darby, Jack R T and Flouri, Dimitra and Cho, Steven K S and Williams, Georgia K and Holman, Stacey L and Meakin, Ashley S and Wiese, Michael D and David, Anna L and Macgowan, Christopher K and Seed, Mike and Melbourne, Andrew and Morrison, Janna L},
  title = {Maternal tadalafil treatment does not increase uterine artery blood flow or oxygen delivery in the pregnant ewe},
  journal = {Experimental Physiology},
  year = {2024},
  doi = {10.1113/ep091593}
}
Kostenlos starten →